Stocks to buy

Moderna (NASDAQ:MRNA) is one of those stocks you trade on news because fundamentals don’t exist. MRNA stock, which only came public late last year, has a market capitalization of $22 billion after racking up sales of $60 million for all of 2019. Source: Shutterstock When it came public I recommended readers buy it. Those who

At first, Qualcomm (NASDAQ:QCOM) stock fell off a cliff in response to the Covid-19 pandemic, with shares dropping from $90 in late February to $58 in late March. Then, QCOM stock sharply reversed course and rallied all the way back to $90 on optimism that the pandemic will inflict only temporary and minor damage on

Editor’s note: This article is part of InvestorPlace.com’s Best Stocks for 2020 contest. Matt McCall’s pick for the contest is Aimmune Therapeutics (NASDAQ:AIMT). Six months ago, I introduced you to Aimmune Therapeutics (NASDAQ:AIMT) as my pick in the Best Stocks for 2020 contest. It’s a leading biopharmaceutical that focuses specifically on the unmet needs of people who suffer

Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2020 contest. Jason Moser’s pick for the contest is Wayfair (NYSE:W). To say that 2020 has been a crazy year for the stock market would be putting it mildly. And what about for my InvestorPlace.com Best Stocks pick? To say that 2020 has been a crazy year for shareholders

Lululemon (NASDAQ:LULU) has been lagging since the company reported earnings in early June. However, LULU stock caught a bid on June 30, on news that it will acquire Mirror for $500 million. Source: Sorbis / Shutterstock.com Shares closed off the highs, but still climbed 6% on the day. Why the enthusiasm? Because Lululemon bought into a

At the beginning of the week, DocuSign (NASDAQ:DOCU) stock saw its share price decline. Investors looked at economic reopening across the U.S. as a negative for the firm’s future performance. DocuSign specializes in orchestrating contracts online and is best-known for its eSignature service, which allows people to sign contracts electronically.  Source: Sundry Photography / Shutterstock.com When

Editor’s note: This article is part of InvestorPlace.com’s Best Stocks for 2020 contest. Eric Fry’s pick for the contest is Freeport-McMoRan (NYSE:FCX). When we last discussed Freeport-McMoRan (NYSE:FCX), the novel coronavirus pandemic was in full force, the U.S. stock market was struggling to recover from a wicked 34% drop and copper prices had tumbled to a three-year low. This

If you can ignore the humidity and 90-degree temperatures, you can almost convince yourself it’s March and not July. Spring training baseball is restarting and professional basketball and hockey playoffs are around the corner. If you hold Penn National Gaming (NASDAQ:PENN) stock, these are all good signs. Source: Casimiro PT / Shutterstock.com The novel coronavirus

The Institute for Supply Management supplies a monthly look at the U.S. manufacturing market. In April, that index hit an 11-year low. But since then, the numbers have been rising. They’re not going wild, but they’re rising. You have seen this in the housing market where new home purchases are growing — mortgage demand is

I’ve been recommending Square (NYSE:SQ) for this entire year. Admittedly, at first that call looked a bit shaky. The novel coronavirus pandemic sent stocks plunging — and Square stock wasn’t immune. Source: IgorGolovniov / Shutterstock.com The company’s exposure to small businesses suggested significant risk if the broader economy went into a tailspin. At the lows,

Most investors won’t consider buying over-the-counter stocks because they think they are illiquid and thinly traded. The reality is that in 2019, a total of $329 billion in OTC stocks changed hands, providing more than 10,750 stocks with an additional marketplace for interested U.S. investors.  Oxford Metrica, in conjunction with the OTC Markets Group, published

Editor’s note: This article is a part of InvestorPlace.com’s Best Stocks for 2020 contest. The Readers’ Choice pick for the contest is Apple (NASDAQ:AAPL). Despite all the chaos in the stock market this quarter, investors have been able to count on a few certainties. You’re likely reading this on an iPhone or a Mac, perhaps an iPad. And if

The coronavirus outbreak has caused a lot of negative impact on consumer demand, unemployment and stocks in industries like travel and leisure took a big hit. During this pandemic, consumers changed their preferences and way of living in a way nobody would have imagined before. Shares of Zoom (NASDAQ:ZM) performed very well during this pandemic.

Last year wasn’t a good year for pot stocks. The first half of 2020 hasn’t been the best, either. But the recent poor performance in the space shouldn’t keep you away from opportunities with Canopy Growth (NYSE:CGC) stock. Source: Shutterstock Why? Multiple reasons. Firstly, a strong balance sheet, courtesy of its largest investor, Constellation Brands

What’s next for JetBlue (NASDAQ:JBLU) stock? Like the company’s rivals, its shares soared earlier this month, as investors placed their bets on a comeback by the airlines. But, as novel coronavirus cases have started to surge again, JetBlue’s shares are starting to pull back. Source: Roman Tiraspolsky / Shutterstock.com In short, we could soon be

With a coronavirus vaccine looking more likely and the sales of electric cars poised to accelerate, General Electric (NYSE:GE) shares seem very attractive. Moreover, the company’s new offshore wind turbine should generate tremendous value for long-term investors in GE stock. Source: JPstock / Shutterstock.com The chances of a viable coronavirus vaccine emerging within the next

Investing in marijuana stocks has been anything but smooth lately. The cannabis industry was no more immune to the novel coronavirus than the rest of the wider markets. However, that doesn’t mean it’s time to abandon pot stocks altogether. The story of 2020 is still unfinished, and there’s comeback potential for a number of stocks

The novel coronavirus pandemic has swept away several industries but has been a bit of a blessing for the biotech sector. iBio (NYSEMKT:IBIO) is one company that is benefiting from the hype surrounding the push for a vaccine, as iBio stock gained 490% this year. Source: Shutterstock As I discussed in my previous article, iBio’s

Canopy Growth (NYSE:CGC) and some of its marijuana equity peers are in the midst of a mini-resurgence. CGC stock is higher by almost 33% in the current quarter. As impressive as that move is, Canopy would need to roughly quadruple to get back to its 2018 high. Source: Shutterstock Over the near-term, asking Canopy or

The stock market rally after the novel coronavirus selloff has been stellar. Besides expansionary monetary policies, strong fundamentals have triggered the rally for several stocks and industries. And in particular, tech stocks have been on fire. In fact, it’s the big names in the technology sector that have continued to deliver strong numbers. Innovation-driven business